| Literature DB >> 33483255 |
Emily C Daykin1, Emory Ryan1, Ellen Sidransky2.
Abstract
Gaucher disease (GD), resulting from biallelic mutations in the gene GBA1, is a monogenic recessively inherited Mendelian disorder with a wide range of phenotypic presentations. The more severe forms of the disease, acute neuronopathic GD (GD2) and chronic neuronopathic GD (GD3), also have a continuum of disease severity with an overlap in manifestations and limited genotype-phenotype correlation. In very young patients, assigning a definitive diagnosis can sometimes be challenging. Several recent studies highlight specific features of neuronopathic GD that may provide diagnostic clues. Distinguishing between the different GD types has important therapeutic implications. Currently there are limited treatment options specifically for neuronopathic GD due to the difficulty in delivering therapies across the blood-brain barrier. In this work, we present both classic and newly appreciated aspects of the Gaucher phenotype that can aid in discriminating between acute and chronic neuronopathic GD, and highlight the continuing therapeutic challenges. Published by Elsevier Inc.Entities:
Keywords: GBA1; Gaucher disease; Glucocerebrosidase; Neuronopathic; Newborn screening; Next-generation sequencing
Mesh:
Substances:
Year: 2021 PMID: 33483255 PMCID: PMC7884077 DOI: 10.1016/j.ymgme.2021.01.002
Source DB: PubMed Journal: Mol Genet Metab ISSN: 1096-7192 Impact factor: 4.797